HIF1? and HIF2? regulate non-small-cell lung cancer dedifferentiation via expression of Sox2 and Oct4 under hypoxic conditions

被引:4
|
作者
Xiong, Shuanglong [1 ]
Wang, Donglin [1 ]
Tang, Yin [1 ]
Lu, Songmei [1 ]
Huang, Lumi [1 ]
Wu, Zhijuan [1 ]
Lei, Shuangyi [1 ]
Liang, Guanzhong [1 ]
Yang, Dan [1 ]
Li, Dairong [1 ]
Li, Yan [1 ,2 ]
机构
[1] Chongqing Univ Canc Hosp, Chongqing Key Lab Translat Res Canc Metastasis & I, Chongqing 400030, Peoples R China
[2] Chongqing Univ Canc Hosp, 181 Hanyu Rd, Chongqing 400030, Peoples R China
关键词
Lung cancer stem cells; Hypoxia; Dedifferentiation; HIF1? and HIF2; Sox2 and Oct4; STEM; PROMOTES; PHENOTYPES;
D O I
10.1016/j.gene.2023.147288
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective: To explore HIF1 alpha and HIF2 alpha regulate the dedifferentiation of lung cancer cells under hypoxic conditions through Sox2 and Oct4. Materials and methods: HIF1 alpha, HIF2 alpha, Sox2 and Oct4 expression was analysed in lung cancer tissues. We analysed sphere formation by single-cell of differentiated lung cancer under hypoxia, and detected the expression of CD133, CD44, Sox2, Oct4, HIF1 alpha and HIF2 alpha. We knocked out HIF1 alpha, HIF2 alpha, Sox2 or Oct4 in cells, cultured the cells under hypoxic conditions and detected CD133 and CD44 using western blotting. We also detected the apoptosis rate of cells with HIF1 alpha, HIF2 alpha, Sox2 or Oct4 knockout. Results: There was more sphere formation of differentiated lung cancer cells under hypoxic conditions than of control cells under normoxic conditions. These newly formed spheres highly expressed CD133 and CD44. TCGA database showed high expression of HIF1 alpha and HIF2 alpha in lung cancer tissues. After knocking out HIF1 alpha and HIF2 alpha, the expression of Sox2, Oct4, CD133 and CD44 decreased significantly, and after knocking out Sox2 or Oct4, the expression of CD133 and CD44 decreased. Conclusion: HIF1 alpha and HIF2 alpha regulate non-small-cell lung cancer dedifferentiation through Sox2 and Oct4 under hypoxic conditions.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines
    Western, P
    Maldonado-Saldivia, J
    Van den Bergen, J
    Hajkova, P
    Saitou, M
    Barton, S
    Surani, MA
    STEM CELLS, 2005, 23 (10) : 1436 - 1442
  • [42] Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer
    Erdem, Johanna Samulin
    Skaug, Vidar
    Bakke, Per
    Gulsvik, Amund
    Haugen, Aage
    Zienolddiny, Shanbeh
    BMC CANCER, 2016, 16
  • [43] Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer
    Johanna Samulin Erdem
    Vidar Skaug
    Per Bakke
    Amund Gulsvik
    Aage Haugen
    Shanbeh Zienolddiny
    BMC Cancer, 16
  • [44] The Impact of Calcineurin B Homologous Protein Isoform 2 Expression on Non-small Cell Lung Cancer Cell Function under Hypoxic Conditions
    Buchholz, Scott
    Sieverding, Shelby
    Provost, Joseph
    Wallert, Mark
    FASEB JOURNAL, 2015, 29
  • [45] The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1α Levels and Colorectal Cancer Cell Survival under Hypoxia
    Di Conza, Giusy
    Cafarello, Sarah Trusso
    Loroch, Stefan
    Mennerich, Daniela
    Deschoemaeker, Sofie
    Di Matteo, Mario
    Ehling, Manuel
    Gevaert, Kris
    Prenen, Hans
    Zahedi, Rene Peiman
    Sickmann, Albert
    Kietzmann, Thomas
    Moretti, Fabiola
    Mazzone, Massimiliano
    CELL REPORTS, 2017, 18 (07): : 1699 - 1712
  • [46] FGFR1, 2 and 3 Expression in Early Stage Non-Small-Cell Lung Cancer
    Engelsman-Theelen, Willemijn
    Heuvel, Michel V. D.
    Willems, Stefan
    Mittempergher, Lorenza
    Bosma, Astrid J.
    Peters, Dennis D.
    Blaauwgeers, Hans J.
    Japenga, Eva J.
    Van Noesel, Carel J.
    Bernards, Rene
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S715 - S715
  • [47] Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
    Li, Fengzhi
    Aljahdali, Ieman A. M.
    Zhang, Renyuan
    Nastiuk, Kent L.
    Krolewski, John J.
    Ling, Xiang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [48] Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma
    Fengzhi Li
    Ieman A. M. Aljahdali
    Renyuan Zhang
    Kent L. Nastiuk
    John J. Krolewski
    Xiang Ling
    Journal of Experimental & Clinical Cancer Research, 40
  • [49] Photodynamic therapy upregulates expression of HIF-1α and PD-L1 in related pathways and its clinical relevance in non-small-cell lung cancer
    Sun, Wen
    Cheng, Yuan
    Ma, Xiaoyu
    Jin, Zhou
    Zhang, Qi
    Wang, Guangfa
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [50] Endobronchial Ultrasound Doppler Image Features Correlate with mRNA Expression of HIF1-α and VEGF-C in Patients with Non-Small-Cell Lung Cancer
    Nakajima, Takahiro
    Anayama, Takashi
    Koike, Terumoto
    Shingyoji, Masato
    Castle, Lianne
    Kimura, Hideki
    Yoshino, Ichiro
    Yasufuku, Kazuhiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : 1661 - 1667